• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒预防措施结合接触者追踪在减少甲型H1N1流感(2009年)传播方面的有效性:一项系统评价。

Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review.

作者信息

Mizumoto Kenji, Nishiura Hiroshi, Yamamoto Taro

机构信息

School of Public Health, The University of Hong Kong, 100 Cyberport Road, Pokfulam, Hong Kong, China.

出版信息

Theor Biol Med Model. 2013 Jan 16;10:4. doi: 10.1186/1742-4682-10-4.

DOI:10.1186/1742-4682-10-4
PMID:23324555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3563494/
Abstract

BACKGROUND

During the very early stage of the 2009 pandemic, mass chemoprophylaxis was implemented as part of containment measure. The purposes of the present study were to systematically review the retrospective studies that investigated the effectiveness of antiviral prophylaxis during the 2009 pandemic, and to explicitly estimate the effectiveness by employing a mathematical model.

METHODS

A systematic review identified 17 articles that clearly defined the cases and identified exposed individuals based on contact tracing. Analysing a specific school-driven outbreak, we estimated the effectiveness of antiviral prophylaxis using a renewal equation model. Other parameters, including the reproduction number and the effectiveness of antiviral treatment and school closure, were jointly estimated.

RESULTS

Based on the systematic review, median secondary infection risks (SIRs) among exposed individuals with and without prophylaxis were estimated at 2.1% (quartile: 0, 12.2) and 16.6% (quartile: 8.4, 32.4), respectively. A very high heterogeneity in the SIR was identified with an estimated I2 statistic at 71.8%. From the outbreak data in Madagascar, the effectiveness of mass chemoprophylaxis in reducing secondary transmissions was estimated to range from 92.8% to 95.4% according to different model assumptions and likelihood functions, not varying substantially as compared to other parameters.

CONCLUSIONS

Only based on the meta-analysis of retrospective studies with different study designs and exposure settings, it was not feasible to estimate the effectiveness of antiviral prophylaxis in reducing transmission. However, modelling analysis of a single outbreak successfully yielded an estimate of the effectiveness that appeared to be robust to model assumptions. Future studies should fill the data gap that has existed in observational studies and allow mathematical models to be used for the analysis of meta-data.

摘要

背景

在2009年大流行的极早期阶段,实施了大规模化学预防作为防控措施的一部分。本研究的目的是系统回顾调查2009年大流行期间抗病毒预防效果的回顾性研究,并通过数学模型明确估计其效果。

方法

一项系统回顾确定了17篇文章,这些文章明确界定了病例,并通过接触者追踪确定了暴露个体。通过分析一次特定的学校引发的疫情,我们使用更新方程模型估计了抗病毒预防的效果。同时联合估计了其他参数,包括繁殖数、抗病毒治疗的效果和学校关闭的效果。

结果

基于系统回顾,接受预防和未接受预防的暴露个体中的中位继发感染风险(SIR)分别估计为2.1%(四分位数:0,12.2)和16.6%(四分位数:8.4,32.4)。发现SIR存在非常高的异质性,估计的I²统计量为71.8%。根据马达加斯加的疫情数据,根据不同的模型假设和似然函数,大规模化学预防在减少继发传播方面的效果估计在92.8%至95.4%之间,与其他参数相比变化不大。

结论

仅基于对具有不同研究设计和暴露情况设置的回顾性研究进行荟萃分析,估计抗病毒预防在减少传播方面的效果是不可行的。然而,对一次单一疫情的模型分析成功得出了一个效果估计值,该估计值似乎对模型假设具有稳健性。未来的研究应填补观察性研究中存在的数据空白,并允许使用数学模型进行元数据分析。

相似文献

1
Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review.抗病毒预防措施结合接触者追踪在减少甲型H1N1流感(2009年)传播方面的有效性:一项系统评价。
Theor Biol Med Model. 2013 Jan 16;10:4. doi: 10.1186/1742-4682-10-4.
2
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
3
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
4
Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.甲型和乙型流感预防与治疗的系统评价及经济决策建模
Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. doi: 10.3310/hta7350.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Missing pieces: People in models.缺失的部分:模型中的人。
Glob Epidemiol. 2023 Dec;5:100096. doi: 10.1016/j.gloepi.2022.100096. Epub 2023 Jan 5.
2
Effectiveness of Contact Tracing for Viral Disease Mitigation and Suppression: Evidence-Based Review.接触者追踪在病毒性疾病缓解和抑制中的效果:基于证据的综述。
JMIR Public Health Surveill. 2021 Oct 6;7(10):e32468. doi: 10.2196/32468.
3
Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations.流感的预防与治疗:选择、抗病毒敏感性及现有建议

本文引用的文献

1
Toward unbiased assessment of treatment and prevention: modeling household transmission of pandemic influenza.实现治疗和预防措施的公正评估:大流行性流感家庭传播建模。
BMC Med. 2012 Oct 9;10:118. doi: 10.1186/1741-7015-10-118.
2
Estimation of outbreak severity and transmissibility: Influenza A(H1N1)pdm09 in households.家庭中甲型 H1N1pdm09 流感的暴发严重程度和传染性估计。
BMC Med. 2012 Oct 9;10:117. doi: 10.1186/1741-7015-10-117.
3
A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation.
GMS Infect Dis. 2021 Apr 30;9:Doc02. doi: 10.3205/id000071. eCollection 2021.
4
Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014.2008-2014 年台湾地区长期护理机构中使用抗病毒药物控制流感爆发的情况。
Influenza Other Respir Viruses. 2018 Mar;12(2):287-292. doi: 10.1111/irv.12536. Epub 2018 Jan 28.
5
Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis.评估关于遏制大流行性流感传播干预措施有效性的知识状况:一项系统评价与叙述性综合分析
PLoS One. 2016 Dec 15;11(12):e0168262. doi: 10.1371/journal.pone.0168262. eCollection 2016.
6
Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge.从宿主内感染动态跨越到宿主间传播适应性:当前假设与知识的探讨
Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675). doi: 10.1098/rstb.2014.0302.
7
The impact of model building on the transmission dynamics under vaccination: observable (symptom-based) versus unobservable (contagiousness-dependent) approaches.建模对疫苗接种下传播动力学的影响:可观察(基于症状)与不可观察(传染性相关)方法。
PLoS One. 2013 Apr 12;8(4):e62062. doi: 10.1371/journal.pone.0062062. Print 2013.
8
Modeling the obesity epidemic: social contagion and its implications for control.模拟肥胖流行:社会传染及其对控制的影响。
Theor Biol Med Model. 2013 Mar 9;10:17. doi: 10.1186/1742-4682-10-17.
9
Epidemiological determinants of successful vaccine development.成功疫苗研发的流行病学决定因素。
Int J Med Sci. 2013;10(4):382-4. doi: 10.7150/ijms.5689. Epub 2013 Feb 21.
10
Vaccination and clinical severity: is the effectiveness of contact tracing and case isolation hampered by past vaccination?接种疫苗与临床严重程度:既往接种是否会影响接触者追踪和病例隔离的效果?
Int J Environ Res Public Health. 2013 Feb 27;10(3):816-29. doi: 10.3390/ijerph10030816.
基于个体水平数据的似然率和群体更新方程的一般 HIV 发病率推断方案。
PLoS One. 2012;7(9):e44377. doi: 10.1371/journal.pone.0044377. Epub 2012 Sep 12.
4
The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong.2009 年甲型 H1N1 流感大流行的流行病学和公共卫生研究应对措施:来自香港的经验。
Influenza Other Respir Viruses. 2013 May;7(3):367-82. doi: 10.1111/j.1750-2659.2012.00420.x. Epub 2012 Aug 9.
5
The relationship between tuberculosis and influenza death during the influenza (H1N1) pandemic from 1918-19.1918-19 年流感大流行期间肺结核与流感死亡的关系。
Comput Math Methods Med. 2012;2012:124861. doi: 10.1155/2012/124861. Epub 2012 Jul 17.
6
Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.血液科病房中 2009 年甲型 H1N1 流感大流行的爆发:造血干细胞移植受者的致命临床结局和神经氨酸酶 H275Y 突变的出现。
Int J Hematol. 2012 Sep;96(3):364-9. doi: 10.1007/s12185-012-1139-1. Epub 2012 Jul 8.
7
The time required to estimate the case fatality ratio of influenza using only the tip of an iceberg: joint estimation of the virulence and the transmission potential.仅使用冰山一角来估计流感病死率所需的时间:毒力和传播潜力的联合估计。
Comput Math Methods Med. 2012;2012:978901. doi: 10.1155/2012/978901. Epub 2012 May 10.
8
Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis.家庭传播 2009 年甲型 H1N1 流感:系统评价和荟萃分析。
Epidemiology. 2012 Jul;23(4):531-42. doi: 10.1097/EDE.0b013e31825588b8.
9
Real-time investigation of measles epidemics with estimate of vaccine efficacy.实时调查麻疹疫情并评估疫苗效力。
Int J Biol Sci. 2012;8(5):620-9. doi: 10.7150/ijbs.4329. Epub 2012 Apr 23.
10
Case characteristics and use of oseltamivir in children and household contacts.儿童及家庭接触者的病例特征及奥司他韦的使用情况。
Pediatr Infect Dis J. 2012 Jul;31(7):781-3. doi: 10.1097/INF.0b013e318256c06b.